January is the month when most of the world pretends to go to the gym and tries to survive on leftover Christmas cheesecake. But apparently, nobody sent the memo to European R&D labs.

While the rest of the tech world was on a “digital detox,” Venture Capitalists and Angels deployed capital into 74 companies that are trying to do things that are absurdly hard. I am  talking about treating brain tumors with electricity, printing quantum computers in smartphone factories, and powering artificial hearts wirelessly through the skin.

Here is what happened while you were reconsidering your New Year’s resolutions.

🌍 Market Overview

The data for January 2026 is clear: investors are bored with general AI SaaS. The capital is flowing heavily into Energy (batteries, wind), Biotech (the engineering kind, not just drug discovery), and Semiconductors.

• Deal Count: 74 rounds tracked.
• Total Volume: + €1.7 Billion.
• The Geography: UK, France, and Germany are dominating, but Ireland and The Netherlands are punching significantly above their weight, specifically in quantum computing and semiconductor infrastructure.

🚜 AgriTech & Future Food: January 2026 honorable mention market 

If you think food innovation is just another app for meal delivery, think again. January brought a wave of investments into technologies that are fundamentally changing how we produce calories.

We are seeing a shift from “planting seeds” to “engineering biology.” From Aviwell  improving animal health and growth by harnessing the microbiome., to Innocent Meat turning slaughterhouses into bio-breweries, and Mycophyto vaccinating soil with fungi instead of chemicals.

The Commentary: However, I wonder what impact importing cheap food from abroad will have on the development of high-quality food technologies in Europe. Is investing in this sector driven by a desire to change the world, or is it driven by business?

🟢 My Top 10 Picks

These are the deals that actually matter. They aren’t just buzzwords; they represent genuine engineering breakthroughs or scientific pivots. This is where the “Science Risk” is high, but the payoff is astronomical. Maybe they won’t give the best returns but still more interesting than another SaaS, 

1. Equal1 (Ireland)

• Round: Early VC ($60M)
• Investors: Enterprise Ireland, Atlantic Bridge, EIC
• The Tech: They build quantum System-on-Chip (QSoC) processors using standard CMOS technology. By integrating spin qubits directly with control electronics on a single chip, they leverage existing semiconductor foundries for scalable production.
• The Problem: Quantum computers are currently massive, room-sized mainframes requiring complex cooling and cabling. This lack of scalability and high cost prevents widespread adoption in data centers and limits the technology to research labs.

2. Nami Surgical (UK)

• Round: Series A ($1.9M)
• Investors: Eos Advisory, Maven Capital, British Business Investments
• The Tech: High-performance, miniaturized ultrasonic scalpels designed specifically for robotic surgery. Their piezoelectric technology delivers precise cutting and coagulation in a form factor small enough for dexterous robotic arms.
• The Problem: As surgical robots get smaller and more capable, traditional ultrasonic tools remain too bulky and rigid. This mismatch limits the robot’s ability to perform complex, minimally invasive procedures in tight anatomical spaces.

3. Abbelight (France)

• Round: Series B (Undisclosed)
• Investors: AVANT BIO
• The Tech: A plug-and-play module for 3D Single-Molecule Localization Microscopy (SMLM). It transforms standard microscopes into nanoscopes with 15nm resolution, enabling isotropic 3D imaging of cellular structures in real-time.
• The Problem: To cure diseases like Alzheimer’s, scientists need to see molecular mechanisms in 3D. Current super-resolution tools are often limited to 2D, are prohibitively expensive, or require complex, slow setups that stall research.

4. bit.bio (UK)

• Round: Series C ($50M)
• Investors: M&G Investments
• The Tech: opti-ox™ technology deterministically programs stem cells into a precise cell identity. By precisely activating transcription factors, they manufacture consistent batches of specific cells, like neurons or muscle fibers, at industrial scale.
• The Problem: Biological research and drug testing suffer from inconsistency because traditional cell cultures vary wildly between batches. This “biological noise” leads to failed clinical trials and unreliable data in drug discovery.

5. Infinitesima (UK)

• Round: Series B (Undisclosed)
• Investors: Maverick Silicon
• The Tech: The Rapid Probe Microscope (RPM) is a high-speed Atomic Force Microscope for semiconductor fabs. It uses interferometry to provide 3D metrology of wafer surfaces at speeds compatible with high-volume manufacturing lines.
• The Problem: As chips shrink to 2nm, optical microscopes can’t see the features, and electron microscopes are too slow for total quality control. Manufacturers are flying blind, unable to detect nano-defects that kill yield and performance.

6. Orbem (Germany)

• Round: Series B (€55.5M)
• Investors: General Catalyst, 83North, Supernova Invest
• The Tech: Accelerated industrial MRI combined with advanced AI analytics. Their system scans biological objects, like eggs or nuts, on a fast-moving conveyor belt, classifying internal properties in milliseconds without physical contact.
• The Problem: Inspecting the inside of organic products usually requires destroying them or is too slow for factories. For example, billions of male chicks are culled annually because hatcheries can’t determine egg sex non-invasively at speed.

7. Polar Light Technologies (Sweden)

• Round: Early VC (€5M)
• Investors: Unlisted
• The Tech: Polar Light develops pyramidal InGaN/GaN microLEDs grown with a bottom-up process (no etching), enabling sub-micron emitters and demonstrating monolithic RGB emission in the same material system, with pathways toward integration with CMOS backplanes.
• The Problem: Next-gen AR/VR headsets need displays that are incredibly bright yet tiny and power-efficient. Current MicroLED manufacturing is plagued by defects and poor efficiency at small sizes, making consumer adoption impossible.

8. FineHeart (France)

• Round: Series C (€35M)
• Investors: Irdi Capital, Lurra Capital
• The Tech: FineHeart’s ICOMS FlowMaker® is a fully intraventricular, wireless flow accelerator that provides physiological support synchronized with the heart’s contractions, and is recharged via transcutaneous energy transfer eliminating an external driveline
• The Problem: Traditional heart pumps require a power cable passing through the patient’s abdomen, which is a major source of infection and restricts lifestyle. Patients remain tethered to batteries and face high mortality risks from complications.

9. QV Bioelectronics (UK)

• Round: Early VC (£4.5M)
• Investors: Innovate UK, PXN Ventures
• The Tech: The GRACE implant delivers electric field therapy directly to brain tumors. The device is fully implanted within the skull, delivering continuous, targeted disruption to cancer cell division without external wires.
• The Problem: Glioblastoma is an aggressive brain cancer with poor survival rates. Chemotherapy struggles to cross the blood-brain barrier, and current electric field treatments require shaving the head and wearing visible, cumbersome external caps.

10. CoolSem Technologies (Netherlands)

• Round: Seed (Undisclosed)
• Investors: BOM, SHIFT Invest
• The Tech: CoolSem’s WaLTIS replaces conventional substrates through wafer-level substrate removal and bonding to an engineered multilayer stack designed to improve heat flow, manage mechanical stress, and enhance reliability – ositioned as a scalable manufacturing approach.
• The Problem: High-performance AI and 5G chips generate massive heat densities that traditional heatsinks can’t handle. This thermal bottleneck forces processors to throttle performance, wasting energy and limiting computational power.

🟡 Honorable Mentions

These are solid companies, massive infrastructure plays, or technologies that are promising but aren’t as interesting for me as TOP10. But still great technology and a solid piece of deep tech. 

RobCo (Germany)

A leading provider of modular, affordable, and connected robot kits for industrial automation in SMEs. Their patented modular hardware and no-code software platform allow businesses to configure and deploy robot arms for tasks like palletizing or welding in days, not weeks, drastically lowering the barrier to entry for automation.

Quantum Systems (Germany)

Developer of advanced eVTOL (electric Vertical Take-Off and Landing) UAVs for government and commercial clients. Their drones, like the Vector, combine the vertical take-off capability of a helicopter with the efficient forward flight of a fixed-wing aircraft, providing long-range, high-endurance surveillance and reconnaissance capabilities in GPS-denied environments.

VitreaLab (Austria)

Revolutionizing the display industry with their laser-lit chip technology. They embed millions of microscopic laser waveguides into a piece of glass to create displays that are incredibly bright and energy-efficient. This technology addresses the critical bottlenecks of brightness and battery life in AR/VR headsets, paving the way for truly immersive and portable extended reality experiences.

Fractile (UK)

Building a new class of AI chips based on In-Memory Computing architecture. By performing calculations directly where data is stored, they eliminate the massive energy and time cost of moving data between memory and processors. This approach targets the primary bottleneck in running large language models (LLMs), promising orders of magnitude faster and more efficient inference.

Carbonaide (Finland)

Transforming concrete production with carbon dioxide mineralization technology. Their automated process cures precast concrete using CO2 instead of heat or water, permanently trapping the gas within the material. This not only reduces the carbon footprint of cement but also increases the strength and durability of the final product, turning a major pollutant into a building block.

Harmattan AI (France)

Developing advanced autonomous systems for defense applications, specifically focusing on drone swarms. Their AI technology enables multiple unmanned vehicles to operate collaboratively and make decisions in real-time without GPS or direct human control. This is critical for modern warfare where electronic jamming is prevalent, ensuring mission success in contested environments.

D-Orbit (Italy)

A market leader in space logistics and orbital transportation services. Their ION Satellite Carrier acts as a “last-mile delivery” vehicle in space, carrying multiple satellites to orbit and releasing them into precise, distinct orbital slots. This service optimizes launch costs and mission flexibility, serving as the critical logistics backbone for the rapidly growing New Space economy.

ShanX Medtech (Netherlands)

Addressing the global crisis of antibiotic resistance with a rapid diagnostic test. Their microfluidic chip technology can determine the effectiveness of an antibiotic against a specific bacterial infection in just one hour, compared to the standard 2-3 days. This empowers doctors to prescribe the correct treatment immediately, saving lives and reducing the misuse of broad-spectrum antibiotics.

BW Ideol (France)

A global leader in floating offshore wind technology. Their patented “Damping Pool” solution is a ring-shaped concrete floating foundation that stabilizes wind turbines in deep waters where fixed-bottom foundations are not feasible. This technology unlocks the vast potential of deep-sea wind energy, which offers stronger and more consistent wind resources compared to shallow coastal areas.

🕵️‍♂️ Investor Activity: Following the “Smart Money”

The Silicon Valley Invasion Continues It’s impossible to ignore Sequoia and Lightspeed jumping into RobCo (Germany). When the giants of Sand Hill Road invest in Munich-based robotics, it signals that Europe is winning the “Physical AI” argument. They know the next wave of automation requires hardware, and Europe has the engineers.

The Corporate Deep Pockets T-Capital (Deutsche Telekom) in Quantum Systems and Holcim in BW Ideol show that industrial giants are terrified of being disrupted. They are no longer just watching; they are buying their way into the future of infrastructure.

The Bottom Line: The market has matured. Investors stopped looking for the next GPT wrappers and started looking for the next “Intel,” “SpaceX,” and “Moderna.” I hope that they will find in Europe soon.